search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Laboratory Products focus on


BIO International 2013 Review Trevor R. Hopkins, Contributing Editor, International Labmate Ltd. Email: trevor@intlabmate.com


The annual BIO International Convention, organised and hosted by the Biotechnology Industry Organization (BIO), is focused on supporting BIO programs and initiatives and is the global event for biotechnology bringing together industry leaders for networking, partnering, and deal making. BIO, as a powerful industry group, works year round to create a policy environment that permits the industry to continue to fulfil its vision of bettering life and the world through biotechnology advances.


BIO members include more than 1,100 biotechnology companies, academic research institutions, state funded biotechnology groups and related organisations across the United States and in more than 30 other countries worldwide. The BIO membership is focused on Global Innovations and Markets, US Health Policies and Reimbursement, Biosecurity, Biotechnology Business Development, Food and Agriculture, and Biofuels and Bio based Chemicals.


BIO International Convention is the world's largest meeting of, and for, the biotechnology industry. The BIO International convention 2013 was held at McCormick Place in Chicago, IL. USA, 22-25 April, with 13,594 registered visitors from 47 US states, the District of Columbia, Puerto Rico, US Virgin Islands and 62 other countries.


The top 10 largest international delegations included (in order): Canada, United Kingdom, Germany, France, Japan, South Korea, China, Brazil, Turkey and Australia.


Attendance was lower in 2013 compared to previous years mainly due to a competitive pharmaceutical manufacturing meeting and exhibition, Interphex 2013 USA, which ran concurrently from 23-25th April in New York USA. Interphex boasted a 20% increase in attendance this year.


The BIO Convention program featured more than 125 breakout sessions across 17 tracks, which included Achieving Regulatory Approval and Compliance for Biotechnology companies, Biofuels and Bio based Chemicals, Biotech Patenting and Technology Transfer, Business Development, Finance, Food and Agriculture.


The BIO Business Forum, a cornerstone of the BIO Convention provides an opportunity for biotechnology and pharmaceutical companies, academic research institutions and investors from around the world to schedule one-on-one meetings and discuss potential business opportunities, hosted a record-number of 25,573 meetings in 2013 and scheduled partnering meetings between 2,800 companies, featuring 167 corporate presentations, including the Rare Disease Partnering Summit featuring presentations by pediatric institutions. These partnering meetings and panel sessions cover the latest science, policy issues and business opportunities and challenges facing the biotechnology industry today.


In its second year, Exhibitor partnering hosted 5,400 meetings, a 25 percent increase over 2012.


1,722 exhibitors covered 180,000 ft2


international pavilions. 2012 addition, the 180,550 ft2


along with 60 US state and BIO Exhibition featured more than


2,000 exhibitors. The BIO Exhibition included 34 country and 26 state pavilions.


BIO works all year to create a policy environment that permits the industry to continue to fulfil its vision of bettering the world through biotechnology advances.


This year’s convention was attended by Ten US Governors: Iowa Governor Branstad, Illinois Governor Quinn, Indiana Governor Pence, Kentucky Governor Beshear, Missouri Governor Nixon, North Carolina Governor McCrory, Pennsylvania Governor Corbett, South Dakota Governor Daugaard, Texas Governor Perry and Wisconsin Governor Walker.


"The 2013 BIO International Convention brought together global leaders from industry, government and academia who are working together to move innovation forward," said BIO President and CEO Jim Greenwood. "Our Convention provides biotech leaders with opportunities to showcase our industry's promise to offer real solutions to the most pressing global challenges such as curing disease, reducing health care costs, combating hunger, discovering alternative forms of energy and creating high-wage jobs."


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156  |  Page 157  |  Page 158  |  Page 159  |  Page 160  |  Page 161  |  Page 162  |  Page 163  |  Page 164  |  Page 165  |  Page 166  |  Page 167  |  Page 168  |  Page 169  |  Page 170  |  Page 171  |  Page 172  |  Page 173  |  Page 174  |  Page 175  |  Page 176  |  Page 177  |  Page 178  |  Page 179  |  Page 180  |  Page 181  |  Page 182  |  Page 183  |  Page 184  |  Page 185  |  Page 186  |  Page 187  |  Page 188  |  Page 189  |  Page 190  |  Page 191  |  Page 192  |  Page 193  |  Page 194  |  Page 195  |  Page 196  |  Page 197  |  Page 198  |  Page 199  |  Page 200  |  Page 201  |  Page 202  |  Page 203  |  Page 204  |  Page 205  |  Page 206  |  Page 207  |  Page 208  |  Page 209  |  Page 210  |  Page 211  |  Page 212  |  Page 213  |  Page 214  |  Page 215  |  Page 216  |  Page 217  |  Page 218  |  Page 219  |  Page 220  |  Page 221  |  Page 222